REFERENCE FILE
Tirzepatide
Read the record, then work through the questions.
Reference details
Status as of
- Regulatory category
- Approved product
- Evidence category
- Randomized evidence
- Mechanism
- Activates GIP and GLP-1 receptors.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- Severe or persistent gastrointestinal symptoms: contact a clinician.
- Formulation and route
- Subcutaneous injection.
- Approval scope
- Zepbound: weight management for eligible patients.
A SECOND LOOK
A question to carry into the reading
Use this tirzepatide profile to practice checking which version of a reference you are reading. Find the document’s own publication or revision date, then distinguish it from the date someone accessed it. If you encounter another version, compare the relevant passage before deciding that the information changed. A different date or page layout alone does not tell you which wording was revised. Keep the document title, version, and passage together in your notes. If the citation does not identify the version clearly, make that a question to resolve rather than choosing whichever copy best fits your expectation.
Questions to keep beside the page
- Can I identify the exact document version behind this profile’s citation?
- Which date belongs to the document, and which records when it was checked?
- If versions differ, what changed in the passage supporting this statement?
Sources for this file
- ZEPBOUNDNLM · Checked
- Zepbound approvalFDA · Checked
FROM THE REFERENCE DESK